Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.19.2
Stockholders' Equity (Details)
9 Months Ended
Sep. 30, 2018
USD ($)
$ / shares
shares
STOCKHOLDERS' EQUITY (DEFICIT):  
Stock options outstanding, beginning | shares 0
Stock options acquired in merger | shares 133,711
Stock options granted | shares 68,347
Stock options forfeited | shares (45,178)
Stock options outstanding, ending | shares 156,880
Weighted average exercise price outstanding, beginning | $ / shares $ 0
Weighted average exercise price acquired in merger | $ / shares 36.42
Weighted average exercise price granted | $ / shares 12.24
Weighted average exercise price forfeited | $ / shares 11.64
Weighted average exercise price outstanding, ending | $ / shares $ 33
Weighted average remaining contractual life, beginning 0 years
Weighted average remaining contractual life acquired in merger 4 years 1 month 17 days
Weighted average remaining contractual life granted 9 years 6 months 4 days
Weighted average remaining contractual life forfeited 0 years
Weighted average remaining contractual life, ending 4 years 10 months 28 days
Aggregate intrinsic value outstanding, beginning | $ $ 0
Aggregate intrinsic value acquired in merger | $ 0
Aggregate intrinsic value granted | $ 0
Aggregate intrinsic value forfeited | $ 0
Aggregate intrinsic value outstanding, ending | $ $ 0